Leukemia Diagnostic Tool for Clinical Teams
Haem.io (Haemio) is a hematology diagnostic platform built to help teams handle high-complexity leukemia and myeloid disease classification. It combines deterministic algorithmic execution with explainable diagnostic logic.
The current product scope supports AML and MDS pathways. Broader leukemia coverage is part of the roadmap, and this page will expand as additional disease modules become production-ready.
Current capabilities
- WHO 2022 and ICC 2022 classification logic for AML and MDS
- Risk stratification support for AML and MDS contexts
- Traceable decision paths for every diagnostic output